Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.
about
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesiclesPhosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse modelsRegulation and function of the FGF23/klotho endocrine pathwaysThe role of phosphatases in the initiation of skeletal mineralizationHierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeletonInfrared imaging microscopy of bone: illustrations from a mouse model of Fabry diseaseLoss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcificationPhosphate induces formation of matrix vesicles during odontoblast-initiated mineralization in vitroEffects of 24R,25- and 1alpha,25-dihydroxyvitamin D3 on mineralizing growth plate chondrocytes.Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics.Enzyme replacement therapy for murine hypophosphatasiaCellular function and molecular structure of ecto-nucleotidases.Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasiaAltered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcificationImprovement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.Biomineralization and matrix vesicles in biology and pathology.Counter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesisHip geometry variation is associated with bone mineralization pathway gene variants: The Framingham Study.Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank miceModulation of extracellular matrix protein phosphorylation alters mineralization in differentiating chick limb-bud mesenchymal cell micromass culturesAlkaline Phosphatase and Hypophosphatasia.FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.Osteoblast differentiation stage-specific expression of the pyrophosphate-generating enzyme PC-1.ATP and arterial calcification.Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta1 and CD63.Tissue Nonspecific Alkaline Phosphatase (TNAP) Regulates Cranial Base Growth and Synchondrosis Maturation.Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.FGF2 promotes Msx2 stimulated PC-1 expression via Frs2/MAPK signaling.Unique roles of phosphorus in endochondral bone formation and osteocyte maturation.Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg433-->Cys substitution associated with severe hypophosphatasia.Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.Inorganic pyrophosphatase induces type I collagen in osteoblasts.Hypophosphatasia - pathophysiology and treatment.Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy.Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice.
P2860
Q24312159-BADCD668-F5F9-4772-A638-5E1B3AB85BFEQ26852872-0DABA750-9C25-4181-9534-04F46DA61F6DQ26860470-DEAD1CE5-9F8E-40B7-9D69-DFC13E4F1A5AQ27007046-4A8610F6-A29E-45EA-B6B4-A6167A5BAF88Q28306935-7566BEB9-1DC8-4B7E-B255-FD49E69A0F01Q28509709-8E104D01-0D56-4A89-983A-FED05D404878Q28509797-29061700-3EF2-4A34-98B6-437DC59F8737Q30760327-1BF92B0F-23F3-4EE3-870A-3C7AB2AACB67Q33231462-A1650725-2A8F-456D-A213-1E4BC2A4F5CDQ33288810-7494634A-8206-40D1-B432-28789F9CF516Q33748177-57F0F2B1-9882-46AC-8161-9B1DD72DC66BQ34008808-AEC86571-EE44-4483-9702-B8275E142C28Q34031794-977A0D1E-D191-441D-AD9F-66DEF0C7754BQ34111540-C7873EA6-B6A3-42F9-8826-42E0CBCB05E5Q34168605-FA8C0DF3-50EC-477C-9E17-89BCA648CD50Q34637356-9BB23821-EBD9-4F73-961C-352AE000DDECQ34769231-1A037BFF-3102-43F0-B065-45A4FF99E868Q34820039-55940140-8421-449A-B033-230ED1823AEDQ35115937-7DBF6484-4588-464C-A7D6-5A01ACCE59E6Q35518063-BC7F1E82-1704-4624-AF04-ECD68367FD5AQ35853942-A68B0062-F275-489F-B6A2-5CB47FDE0A7DQ35920063-E1069EA7-1242-4BD1-B610-6A6F0785EE5CQ36559683-75A1FC10-BB94-454B-978D-F24D94903CD0Q36741976-80B66448-A56D-439C-99FC-53FD1F9DBDCDQ36778063-D4CA4439-A333-49ED-9673-51523AA7C27BQ37137454-F80D7E80-DAF1-4A2E-953F-D218EE79389CQ37242311-4CE26A3A-9402-4558-98B1-235055F6F1D1Q38080569-6151F021-1C23-493B-9843-E35F700B5A8FQ38338747-8AED77A3-ACAB-4BEA-82E9-958A738D383FQ38404898-3460CF42-611C-4E8C-95E9-1333273F4A73Q38426687-150DD0CA-F4C8-46E1-B848-CE3A95D8D910Q38430529-B4153D43-4A24-4895-BDD4-270A23CB018AQ38552814-F565E82F-9DBA-4B5A-A851-FB1DAD21C806Q38712047-D8D9BD31-DF21-40A6-8B43-393B2EE2488FQ40185045-4482487D-33C7-4CF3-8160-C218147B0777Q41277036-ED558A15-02C9-49BA-896B-52FB93B6C25CQ41869796-530AB41D-6CC9-4904-98DE-F1776C982C57Q42008004-755315E2-2C9E-4869-8005-B544CFB7B383Q42113848-CF8DC02F-038B-473C-BB21-4990A2E1B93DQ42272777-AA8E7FC5-3ABA-4F3D-ACAE-DEB417BA6101
P2860
Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@ast
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@en
type
label
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@ast
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@en
prefLabel
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@ast
Sustained osteomalacia of long ...... erase 1 double-deficient mice.
@en
P2093
P2860
P1476
Sustained osteomalacia of long ...... terase 1 double-deficient mice
@en
P2093
Dympna Harmey
H Clarke Anderson
Joseph B Sipe
José Luis Millán
Nancy P Camacho
Rama Garimella
Robert Terkeltaub
Sarah Tague
Xiaohong Bi
P2860
P304
P356
10.1016/S0002-9440(10)62481-9
P407
P577
2005-06-01T00:00:00Z